Home
HCWB
HCWB News

Latest HCW Biologics Inc. (HCWB) News on November 18, 2025

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results

GlobeNewswire

4 days ago

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results

HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

GlobeNewswire

11 days ago

HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment

GlobeNewswire

a month ago

HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment

HCW Biologics to Participate in the 2025 Maxim Growth Summit

GlobeNewswire

a month ago

HCW Biologics to Participate in the 2025 Maxim Growth Summit

HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer

GlobeNewswire

a month ago

HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer

HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing

GlobeNewswire

2 months ago

HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing

HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development

GlobeNewswire

2 months ago

HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development

HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors

GlobeNewswire

5 months ago

HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors

HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements

GlobeNewswire

5 months ago

HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech

GlobeNewswire

5 months ago

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

GlobeNewswire

6 months ago

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

MT Newswires

6 months ago

HCW Biologics Says Studies Show HCW9206 Fusion Protein Addresses Key Challenges for CAR-T Therapies; Shares Surge

HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization

GlobeNewswire

6 months ago

HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization

MT Newswires

6 months ago

Hcw Biologics Insider Bought Shares Worth $2,405,000, According to a Recent SEC Filing

MT Newswires

8 months ago

HCW Biologics to Implement 1-for-40 Reverse Stock Split

HCW Biologics Announces 1-for-40 Reverse Stock Split

GlobeNewswire

8 months ago

HCW Biologics Announces 1-for-40 Reverse Stock Split

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results

GlobeNewswire

8 months ago

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results

HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

GlobeNewswire

8 months ago

HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

MT Newswires

9 months ago

Top Midday Gainers

MT Newswires

9 months ago

HCW Biologics Says FDA Approves Trial of HCW9302 to Treat Alopecia Areata; Shares Rise Pre-Bell

HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

GlobeNewswire

9 months ago

HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

HCW Biologics Insiders Placed Bullish Bets Worth US$2.50m

Simply Wall St.

10 months ago

HCW Biologics Insiders Placed Bullish Bets Worth US$2.50m

HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

GlobeNewswire

10 months ago

HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

MT Newswires

a year ago

HCW Biologics Shares Fall Amid Delisting Notice From Nasdaq

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

GlobeNewswire

a year ago

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

HCW Biologics prices $6.9M registered direct offering at $1.03 per share

TipRanks

a year ago

HCW Biologics prices $6.9M registered direct offering at $1.03 per share

MT Newswires

a year ago

HCW Biologics to Raise $6.9 Million in Gross Proceeds From Direct Offering, Private Placement; Shares Extend Gains Premarket

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

GlobeNewswire

a year ago

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

MT Newswires

a year ago

Sector Update: Health Care Stocks Mixed in Late Afternoon Trading

MT Newswires

a year ago

Top Midday Gainers

Why Is Penny Stock HCW Biologics Surging On Monday?

Benzinga

a year ago

Why Is Penny Stock HCW Biologics Surging On Monday?

MT Newswires

a year ago

HCW Biologics, WY Biotech Sign License Deal for Immunotherapeutic Product Candidate

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

GlobeNewswire

a year ago

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

a year ago

HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction

GlobeNewswire

a year ago

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction

Bullish HCW Biologics Insider Buying Worth US$2.57m Yet To Pay Off

Simply Wall St.

a year ago

Bullish HCW Biologics Insider Buying Worth US$2.57m Yet To Pay Off

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

a year ago

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights

HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

2 years ago

HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

GlobeNewswire

2 years ago

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

Rebecca Byam Bought 122% More Shares In HCW Biologics

Simply Wall St.

2 years ago

Rebecca Byam Bought 122% More Shares In HCW Biologics

Market Exclusive

2 years ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®

GlobeNewswire

2 years ago

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®

Several Insiders Invested In HCW Biologics Flagging Positive News

Simply Wall St.

2 years ago

Several Insiders Invested In HCW Biologics Flagging Positive News

Organigram Announces the First Tranche Closing from BAT Investment

Business Wire

2 years ago

Organigram Announces the First Tranche Closing from BAT Investment

AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal

Zacks

2 years ago

AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal

Alvotech (ALVO) Up on BLA Update for Two Biosimilar Candidates

Zacks

2 years ago

Alvotech (ALVO) Up on BLA Update for Two Biosimilar Candidates

Danimer Scientific Announces New Directors

Business Wire

2 years ago

Danimer Scientific Announces New Directors

ReWalk Robotics (NASDAQ:RWLK investor five-year losses grow to 82% as the stock sheds US$10m this past week

Simply Wall St.

2 years ago

ReWalk Robotics (NASDAQ:RWLK investor five-year losses grow to 82% as the stock sheds US$10m this past week

Early Bird Wins: 3 Stocks to Snag Before the Next Market Rally

InvestorPlace

2 years ago

Early Bird Wins: 3 Stocks to Snag Before the Next Market Rally

Electrovaya to Participate in the iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas Virtual Conference on January 9th and 10th, 2024

ACCESSWIRE

2 years ago

Electrovaya to Participate in the iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas Virtual Conference on January 9th and 10th, 2024

ACCESSWIRE

2 years ago

iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas January 9th-10th 2024

Frequency Electronics, Inc. (NASDAQ:FEIM) is definitely on the radar of institutional investors who own 38% of the company

Simply Wall St.

2 years ago

Frequency Electronics, Inc. (NASDAQ:FEIM) is definitely on the radar of institutional investors who own 38% of the company

Better Home & Finance Holding Company to Participate in the 2024 ICR Conference

Business Wire

2 years ago

Better Home & Finance Holding Company to Participate in the 2024 ICR Conference

Electrovaya Reports Record Revenue of $44.1 Million for Fiscal Year 2023; Up 171% Y/Y

ACCESSWIRE

2 years ago

Electrovaya Reports Record Revenue of $44.1 Million for Fiscal Year 2023; Up 171% Y/Y

Is Now The Time To Look At Buying Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH)?

Simply Wall St.

2 years ago

Is Now The Time To Look At Buying Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH)?

First Savings Financial (FSFG) Could Be a Great Choice

Zacks

2 years ago

First Savings Financial (FSFG) Could Be a Great Choice

inTEST Corporation Launches Next Generation of Induction Heating Systems

Business Wire

2 years ago

inTEST Corporation Launches Next Generation of Induction Heating Systems

An Intrinsic Calculation For Research Solutions, Inc. (NASDAQ:RSSS) Suggests It's 49% Undervalued

Simply Wall St.

2 years ago

An Intrinsic Calculation For Research Solutions, Inc. (NASDAQ:RSSS) Suggests It's 49% Undervalued

3 Vulnerable Retail Stocks That Won’t Survive the Holidays

InvestorPlace

2 years ago

3 Vulnerable Retail Stocks That Won’t Survive the Holidays

We Think Shareholders May Want To Consider A Review Of Allot Ltd.'s (NASDAQ:ALLT) CEO Compensation Package

Simply Wall St.

2 years ago

We Think Shareholders May Want To Consider A Review Of Allot Ltd.'s (NASDAQ:ALLT) CEO Compensation Package

Great week for Karyopharm Therapeutics Inc. (NASDAQ:KPTI) institutional investors after losing 84% over the previous year

Simply Wall St.

2 years ago

Great week for Karyopharm Therapeutics Inc. (NASDAQ:KPTI) institutional investors after losing 84% over the previous year

PR Newswire

2 years ago

NXG NextGen Infrastructure Income Fund (NYSE: NXG) Announces Distributions

Returns Are Gaining Momentum At Big 5 Sporting Goods (NASDAQ:BGFV)

Simply Wall St.

2 years ago

Returns Are Gaining Momentum At Big 5 Sporting Goods (NASDAQ:BGFV)

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

GlobeNewswire

2 years ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

Allot Communications (ALLT) Reports Q3 Loss, Tops Revenue Estimates

Zacks

2 years ago

Allot Communications (ALLT) Reports Q3 Loss, Tops Revenue Estimates

Several Insiders Invested In SHF Holdings Flagging Positive News

Simply Wall St.

2 years ago

Several Insiders Invested In SHF Holdings Flagging Positive News

HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights

GlobeNewswire

2 years ago

HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights

It Looks Like IF Bancorp, Inc.'s (NASDAQ:IROQ) CEO May Expect Their Salary To Be Put Under The Microscope

Simply Wall St.

2 years ago

It Looks Like IF Bancorp, Inc.'s (NASDAQ:IROQ) CEO May Expect Their Salary To Be Put Under The Microscope

Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

GlobeNewswire

2 years ago

Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

PR Newswire

2 years ago

NUTEX HEALTH REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS

Canterbury Park Holding Corporation Reports 2023 Third Quarter Results

GlobeNewswire

2 years ago

Canterbury Park Holding Corporation Reports 2023 Third Quarter Results

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Eastern Company Earnings Call

Innovid Reports Q3 2023 Financial Results

PR Newswire

2 years ago

Innovid Reports Q3 2023 Financial Results

Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

GlobeNewswire

2 years ago

Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

Declining Stock and Solid Fundamentals: Is The Market Wrong About Canterbury Park Holding Corporation (NASDAQ:CPHC)?

Simply Wall St.

2 years ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Canterbury Park Holding Corporation (NASDAQ:CPHC)?

PR Newswire

2 years ago

GoldMining Releases Inaugural Sustainability Report

Thomson Reuters StreetEvents

2 years ago

Q3 2023 GlycoMimetics Inc Earnings Call

Chimerix, Inc. (NASDAQ:CMRX) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Chimerix, Inc. (NASDAQ:CMRX) Q3 2023 Earnings Call Transcript

Chimerix (NASDAQ:CMRX) shareholders have endured a 70% loss from investing in the stock five years ago

Simply Wall St.

2 years ago

Chimerix (NASDAQ:CMRX) shareholders have endured a 70% loss from investing in the stock five years ago

Share on Social Networks: